StonvexLoading…
StonvexStonvexStonvexCore line items from MIRM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $521.31M | $336.89M | $186.37M | $77.06M |
Operating Income | $-22.14M | $-87.61M | $-109.15M | $-131.22M |
Net Income | $-23.36M | $-87.94M | $-163.41M | $-135.66M |
EPS (Diluted) | $-0.47 | $-1.85 | $-4.00 | $-4.02 |
Total Assets | $842.81M | $670.75M | $646.62M | $352.91M |
Total Liabilities | $528.12M | $445.11M | $397.95M | $210.87M |
Cash & Equivalents | $296.68M | $222.50M | $286.33M | $28.00M |
Free Cash Flow OCF − CapEx | $54.87M | $9.33M | $-71.05M | $-120.41M |
Shares Outstanding | 51.90M | 48.34M | 46.72M | 36.96M |